• The document is an intimation regarding the availability of audio recording for the company's Earnings Call held on May 28, 2026.
  • The earnings call discussed the company's operational and financial performance for the quarter and year ended March 31, 2026 (Q4 FY26).
  • The audio recording has been made available on the company's website at: https://www.supriyalifescience.com/ir-financial.php
  • The disclosure was signed by Prachi Suhas Sathe, Company Secretary & Compliance Officer, and filed with both BSE Limited and National Stock Exchange of India Limited.

Additional Notes Section

  • This is a follow-up communication to previous letters dated May 23, 2026 and May 27, 2026.
  • No financial data or specific performance figures were disclosed in this announcement.
  • The document contains standard company contact information including corporate office and factory addresses.